Eisai completes new oral solid-dose plant in Suzhou, China

Eisai's Chinese subsidiary completed a new oral solid dose production facility and administration building at its Suzhou plant in the Suzhou Industrial Park. The facility has capacity for approximately 3 billion tablets formulation and 5 billion tablets packaging per year, doubling the capacity of the current plant.

“Eisai said it sought to strengthen its in-house domestic production system in China, and expand its stable supply chain of pharmaceuticals, through the completion of the OSD production facility at the new Suzhou plant.”genengnews.com

• 1 source
• genengnews.comEisai Completes New Oral Solid-Dose Plant in ChinaAlex PhilippidisJan 15, 2018

Summarized from public sources; check the original articles before acting on it.